ESWL on Disintegration of Renal Stones
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03939325 |
|
Recruitment Status : Unknown
Verified May 2019 by Mohamed Ahmed Mohamed El Taher, Assiut University.
Recruitment status was: Not yet recruiting
First Posted : May 6, 2019
Last Update Posted : May 6, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Renal Stone | Radiation: ESWL |
- Prior to the introduction of extracorporeal shockwave lithotripsy (ESWL) in 1980, the only treatment available for calculi that could not pass through the urinary tract was open surgery. Since then, ESWL has become the preferred tool in the urologist's armamentarium for the treatment of renal stones, , ESWL is minimally invasive, exposes patients to less anaesthesia, and yields equivalent stone-free rates in appropriately selected patients.
- The efficacy of ESWL lies in its ability to pulverize calculi in vivo into smaller fragments, which the body can then expulse spontaneously. Shockwaves are generated and then focused onto a point within the body. The shockwaves propagate through the body with negligible dissipation of energy (and therefore damage) owing to the minimal difference in density of the soft tissues. At the stone-fluid interface, the relatively large difference in density, coupled with the concentration of multiple shockwaves in a small area, produces a large dissipation of energy. Via various mechanisms, this energy is then able to overcome the tensile strength of the calculi, leading to fragmentation. Repetition of this process eventually leads to pulverization of the calculi into small fragments that the body can pass spontaneously and painlessly.
- It is well recognized that the popularity of extracorporeal shock wave lithotripsy (SWL), despite its non-invasive character, has decreased during recent years. This is partly explained by the technological achievements in endoscopy and urologists' enthusiasm for such procedures. Another explanation is that many urologists have been insufficiently successful with SWL. The latter effect might to some extent be a result of the performance of the lithotripter used, but in too many cases, it is evident that the principles of how shock wave lithotripsy should be carried out are poorly appliedical aspect
| Study Type : | Observational [Patient Registry] |
| Estimated Enrollment : | 90 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 2 Weeks |
| Official Title: | Impact of Different Shock Wave Release Frequencies on Disintegration of Renal Stones in Assuit Urology & Nephrology University Hospital |
| Estimated Study Start Date : | May 5, 2019 |
| Estimated Primary Completion Date : | June 2020 |
| Estimated Study Completion Date : | June 2020 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
first group
patient who exposed to frequency 60 shock wave per min
|
Radiation: ESWL
The impact of different frequencies on pattern of disintegration of renal stones |
|
second group
patient who exposed to frequency 80 shock wave per min
|
Radiation: ESWL
The impact of different frequencies on pattern of disintegration of renal stones |
|
third group
patient who exposed to frequency 100 shock wave per min
|
Radiation: ESWL
The impact of different frequencies on pattern of disintegration of renal stones |
- stone free rate [ Time Frame: 2 weeks ]complete disintegration of renal stones or having clinically insignificant gravel smaller than 2 mm
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Pelvic and upper ureteric stones
- Stone size less than 2 cm
- Stone density up to 1000 HU
Exclusion Criteria:
- Lower calycle stone
- Stone size 2 cm or more
- Stone denstiy more than 1000
- age group less than 18 y
- uncontrolled hypertension patient and bleeding disorder
- Pregnancy
- Patients with UPJ obstruction, ureteral strictures,
- Congenital anomalies
- Previous stented ureter
- Narrow neck of the calycx less than 30 %
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03939325
| Contact: Mohamed A EL Taher | 01127204629 | mohamed_el_taher7392@yahoo.com | |
| Contact: Ahmed M Reda | 01005096801 | ahmed_leo@yahh.com |
| Responsible Party: | Mohamed Ahmed Mohamed El Taher, M.B.B.CH, Assiut University |
| ClinicalTrials.gov Identifier: | NCT03939325 |
| Other Study ID Numbers: |
impact of ESWL in Renal Stones |
| First Posted: | May 6, 2019 Key Record Dates |
| Last Update Posted: | May 6, 2019 |
| Last Verified: | May 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Kidney Calculi Nephrolithiasis Calculi Pathological Conditions, Anatomical |
Kidney Diseases Urologic Diseases Urolithiasis Urinary Calculi |

